MarketFrame

FTSE 100 news / Companies and sectors / AstraZeneca / NIPER Raebareli and AstraZeneca India partner on clinical trial sites

NIPER Raebareli and AstraZeneca India partner on clinical trial sites

+5.7 positive

NIPER Raebareli and AstraZeneca India partnered to strengthen clinical research across 25 emerging locations.

13 headlines from 13 outlets, from 15 October 2026 to 17 October 2026. The story's tone is the average of its headlines' own scores.

How each outlet covered it

Average tone of each outlet's headlines in this story. One or two headlines is not a lean: read these as how this story was told, not as a verdict on the outlet.

OutletHeadlinesTone
Indian Pharma Post1+6.0
Inshorts1+5.8
pib.gov.in1+5.8
BioSpectrum India1+5.8
India Business Trade1+5.8
Express Pharma1+5.8
Pragativadi1+5.8
IBTimes India1+5.8
pharma.economictimes.indiatimes.com1+5.7
The News Mill1+5.7
DD India1+5.7
Voice of Healthcare1+5.5
Digital Health News1+5.0

Day by day

Saturday 17 October 2026 1 headline

NIPER Raebareli and AstraZeneca India partnered on clinical research.

Thursday 15 October 2026 12 headlines

NIPER Raebareli and AstraZeneca India partnered to strengthen clinical research across 25 emerging locations.

AstraZeneca: all news analysis · Sector · FTSE 100 news